ME00246B - Formulacije hfa-suspenzija koje sadrže anhidrat - Google Patents

Formulacije hfa-suspenzija koje sadrže anhidrat

Info

Publication number
ME00246B
ME00246B MEP-2008-473A MEP47308A ME00246B ME 00246 B ME00246 B ME 00246B ME P47308 A MEP47308 A ME P47308A ME 00246 B ME00246 B ME 00246B
Authority
ME
Montenegro
Prior art keywords
anhydrate
hfa
suspension formulation
formulation
suspension
Prior art date
Application number
MEP-2008-473A
Other languages
German (de)
English (en)
French (fr)
Inventor
Christel Schmelzer
Original Assignee
Boehringer Ingelheim Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim Pharma filed Critical Boehringer Ingelheim Pharma
Publication of MEP47308A publication Critical patent/MEP47308A/xx
Publication of ME00246B publication Critical patent/ME00246B/me

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/10Dispersions; Emulsions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/007Pulmonary tract; Aromatherapy
    • A61K9/0073Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/008Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy comprising drug dissolved or suspended in liquid propellant for inhalation via a pressurized metered dose inhaler [MDI]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/439Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom the ring forming part of a bridged ring system, e.g. quinuclidine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/10Dispersions; Emulsions
    • A61K9/12Aerosols; Foams
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/06Antiasthmatics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Dispersion Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Otolaryngology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)

Abstract

Pronalazak se odnosi na formulaciju, sa potisnim gasom, suspenzije, kristalnog anhidrata (1α,2β,4β, 5α,7β)-7-[(hidroksidi-2-tienilacetil)oksi]-9,9-dimetil-3-oksa-9-azo-niatriciklo[3.3.1.0 2,4 ]nonan-bromida
MEP-2008-473A 2002-03-28 2003-03-20 Formulacije hfa-suspenzija koje sadrže anhidrat ME00246B (me)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10214264A DE10214264A1 (de) 2002-03-28 2002-03-28 HFA-Suspensionsformulierungen eines Anhydrats
PCT/EP2003/002899 WO2003082244A2 (de) 2002-03-28 2003-03-20 Hfa-suspensionsformulierungen eines anhydrats

Publications (2)

Publication Number Publication Date
MEP47308A MEP47308A (en) 2011-02-10
ME00246B true ME00246B (me) 2011-05-10

Family

ID=28050990

Family Applications (1)

Application Number Title Priority Date Filing Date
MEP-2008-473A ME00246B (me) 2002-03-28 2003-03-20 Formulacije hfa-suspenzija koje sadrže anhidrat

Country Status (21)

Country Link
EP (1) EP1492498A2 (me)
JP (1) JP5147158B2 (me)
KR (1) KR101005717B1 (me)
CN (1) CN1642525A (me)
AU (1) AU2003221509B2 (me)
BR (1) BR0308709A (me)
CA (1) CA2479638C (me)
DE (1) DE10214264A1 (me)
EA (1) EA008610B1 (me)
EC (1) ECSP045322A (me)
HR (1) HRP20040890A2 (me)
IL (1) IL163696A0 (me)
ME (1) ME00246B (me)
MX (1) MXPA04009338A (me)
NO (1) NO20044004L (me)
NZ (1) NZ536030A (me)
PL (1) PL371295A1 (me)
RS (1) RS52481B (me)
UA (1) UA79776C2 (me)
WO (1) WO2003082244A2 (me)
ZA (1) ZA200405637B (me)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101166738B (zh) * 2005-05-02 2011-06-01 贝林格尔·英格海姆国际有限公司 噻托溴铵的新晶型
MX2007013691A (es) * 2005-05-02 2008-01-21 Boehringer Ingelheim Int Nuevas formas cristalinas de bromuro de tiotropio.
AU2015201037C1 (en) * 2009-05-29 2017-07-27 Pearl Therapeutics, Inc. Respiratory delivery of active agents
US8815258B2 (en) 2009-05-29 2014-08-26 Pearl Therapeutics, Inc. Compositions, methods and systems for respiratory delivery of two or more active agents
TWI695723B (zh) * 2009-05-29 2020-06-11 美商沛爾醫療股份有限公司 用於經由呼吸道輸送活性劑的組成物以及相關方法與系統
US20140275517A1 (en) 2013-03-15 2014-09-18 Pearl Therapeutics, Inc. Methods and systems for conditioning of particulate crystalline materials
CN114712337A (zh) * 2016-09-19 2022-07-08 墨西哥氟石股份公司 药物组合物

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3931041C2 (de) * 1989-09-16 2000-04-06 Boehringer Ingelheim Kg Ester von Thienylcarbonsäuren mit Aminoalkoholen, ihre Quaternierungsprodukte, Verfahren zu ihrer Herstellung und diese enthaltende Arzneimittel
PT1102579E (pt) * 1998-08-04 2003-07-31 Jago Res Ag Formulacoes de aerossol medicinais
GB0009606D0 (en) * 2000-04-18 2000-06-07 Glaxo Group Ltd Therapeutic combinations
GB0009592D0 (en) * 2000-04-18 2000-06-07 Glaxo Group Ltd Respiratory combinations
GB0009583D0 (en) * 2000-04-18 2000-06-07 Glaxo Group Ltd Respiratory formulations
GB0009605D0 (en) * 2000-04-18 2000-06-07 Glaxo Group Ltd Medicaments
EP1341538B1 (de) * 2000-10-31 2009-12-23 Boehringer Ingelheim Pharma GmbH & Co.KG Arzneimittelkompositionen aus tiotropiumsalzen und epinastin zur therapie von atemswegserkrankungen
DE10113366A1 (de) * 2001-03-20 2002-09-26 Boehringer Ingelheim Pharma Neue Arzneimittelkompositionen auf der Basis von Anticholinergika und Endothelinantagonisten
DE10111058A1 (de) * 2001-03-08 2002-09-12 Boehringer Ingelheim Pharma Neue Arzneimittelkompositionen auf der Basis von Anticholinergika und NK¶1¶-Rezeptor-Antagonisten

Also Published As

Publication number Publication date
WO2003082244A2 (de) 2003-10-09
KR101005717B1 (ko) 2011-01-05
WO2003082244A3 (de) 2004-02-05
NO20044004L (no) 2004-10-05
CN1642525A (zh) 2005-07-20
JP5147158B2 (ja) 2013-02-20
KR20040098022A (ko) 2004-11-18
EP1492498A2 (de) 2005-01-05
DE10214264A1 (de) 2003-10-16
JP2005527550A (ja) 2005-09-15
BR0308709A (pt) 2005-01-04
AU2003221509A1 (en) 2003-10-13
EA200401159A1 (ru) 2005-04-28
CA2479638C (en) 2011-01-04
PL371295A1 (en) 2005-06-13
ZA200405637B (en) 2005-07-27
RS52481B (en) 2013-02-28
CA2479638A1 (en) 2003-10-09
IL163696A0 (en) 2005-12-18
UA79776C2 (en) 2007-07-25
EA008610B1 (ru) 2007-06-29
MXPA04009338A (es) 2005-01-25
MEP47308A (en) 2011-02-10
HRP20040890A2 (en) 2005-06-30
AU2003221509B2 (en) 2008-01-24
YU86004A (sh) 2006-08-17
ECSP045322A (es) 2005-01-28
NZ536030A (en) 2006-07-28

Similar Documents

Publication Publication Date Title
EA200401142A1 (ru) Микронизированный кристаллический тиотропийбромид
MY129525A (en) Process for preparing an anticholinergic
YU99703A (sh) Kristalni antiholinergik, postupak za njegovo pripremanje i njegova primena u proizvodnji leka
MEP40008A (en) Crystalline monohydrate, method for producing the same and the use thereof in the production of a medicament
NO2022019I1 (no) Eribulin eller et farmasøytisk akseptabelt salt derav - forlenget SPC
CY1105543T1 (el) Σκευασματα εναιωρηματων με hfa που περιεχουν αντιχολινεργικο
DK1401837T3 (da) Purinderivater som A2B-adenosinreceptorantagonister
ES2162614T1 (es) Composiciones formadoras de pelicula que comprenden almidones modificados e iota-carragaenina y metodo para producir capsulas blandas usando las mismas.
RS51436B (en) DERIVATIVES TRIAZOLIL TROPANA KAO MODULATORS CCR5
WO1999066063A3 (en) Nucleosidic and non-nucleosidic folate conjugates
GB2380675A (en) Method of increased bioavailability of nutrients and pharmaceutical preparations with tetrahydropiperine and its analogues and derivatives
AR009413A1 (es) Un compuesto, el cual es un derivado de distamicina benzoheterociclico, su utilizacion, un procedimiento para producirlo y una composicionfarmaceutica que lo comprende
ME00246B (me) Formulacije hfa-suspenzija koje sadrže anhidrat
RS53428B (en) COMPOSITIONS AND ANTI-VIRUS ACTIVITY OF SUBSTITUTED AZAINDOLOXOSCETER PIPERAZINE DERIVATIVES
AR086573A2 (es) Derivados de 5-(piridin-3-il)-1-azabiciclo[3,2,1]octano y octeno, su preparacion y su aplicacion en terapeutica
FI913197A0 (fi) Nya jaeststammar med reducerad foermaoga att metabolisera xylitol, foerfarande foer bildande av dessa och deras anvaendning vid framstaellning av xylitol.
WO2003082855A1 (fr) Agent anti-inflammatoire
WO1994019343A3 (en) Novel use as anti-inflammatory agents for bis-heterocyclic compounds and pharmaceutical compositions thereof
WO2005062913A3 (en) Triplide 5,6-derivatives as immunomodulators and anticancer agents
AU2002328824A1 (en) Isoflavone concentrate and method for production thereof
AU2001292423A1 (en) Formulations for reducing or eliminating toxicity of environmental hormones containing ursodeoxycholic acid
ECSP034921A (es) Anticolinérgico cristalino, metodo para su producción, y uso del mismo en la producción de una droga